It considered ways to:
- make approvals faster and easier
- reduce delays and paperwork
- allow more flexible licensing and registration during testing
- use tools like trial environments and approved test sites.
Respondents supported a more proportionate, risk-based approach for R&D. They also called for clearer and more predictable processes.
We will continue to review the feedback and work with industry on next steps.
Read the full summary on the Consultation Hub.
/Public Release. View in full here.
